Total raised
€87M
€87,394,202
Funding rounds
3
Investors
18
distinct backers
Active since
2018-01
latest 2025-07
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood62
base rate 50% for Series C
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood19
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ €30M+ raised
- ▲ 8y since founding
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-07-31 | Series C | €48M | Allegis Capital,Blue Venture Fund,GV,L&G Capital,Lightrock,Oxford Science Enterprises+3 more | View deal → |
| 2021-08-16 | Series B | €28M | Blue Venture Fund,GV,Optum Ventures,Oxford Sciences Innovation | View deal → |
| 2018-02-01 | Series A | €11M | Andre Crawford-Brunt,Dieter Spälti.,Fushia,GT Healthcare,Neptune,Oxford Sciences Innovation+2 more | View deal → |
Investors
18Related news
- UK-based Ultromics raises €28M to help clinicians diagnose heart disease using AI; here’s howsiliconcanals.com · 2021-08
- tech.eu
- tech.eu